Colin Swenson

Associate Professor

Emory University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Colin Swenson is an Associate Professor at Emory University in the United States. His research primarily focuses on bronchiectasis, nontuberculous mycobacterial infections, and respiratory health in the context of various treatment modalities and patient outcomes. Recent publications include studies on the impact of tobacco smoking in bronchiectasis and the effects of specific biologic therapies on postvaccination immunity during the COVID-19 pandemic.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (6)

Myriam Gharbi

Imperial College London

UNITED KINGDOM

View details

Mark Metersky

University of Connecticut School of Medicine

UNITED STATES

View details

Douglas Hornick

Professor

Iowa State University

UNITED STATES

View details

Radmila Choate

Assistant Research Professor

University of Kentucky

UNITED STATES

View details

Daniel Belz

Johns Hopkins University

UNITED STATES

View details

James Blum

Iowa State University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Colin Swenson

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Nebulized hypertonic saline and positive expiratory pressure device use in patients with bronchiectasis: Analysis from the United States Bronchiectasis and NTM research registry

Plastic Bronchitis in HIV-associated Kaposi Sarcoma.

Patients taking benralizumab, dupilumab, or mepolizumab have lower postvaccination SARS-CoV-2 immunity

The Impact of Tobacco Smoking in Bronchiectasis: Data from the U.S. Bronchiectasis and Nontuberculous Mycobacteria Research Registry

Patient-Reported Symptom and Health-Related Quality-of-Life Validation and Responsiveness During the First 6 Months of Treatment for Mycobacterium avium Complex Pulmonary Disease

Nontuberculous mycobacterial (NTM) infections in bronchiectasis patients: A retrospective US registry cohort study

Secondary Bacterial Pneumonias and Bloodstream Infections in Patients Hospitalized with COVID-19.

Aerosolized Liposomal Amikacin and Laryngeal Injury

Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis.

ATS Core Curriculum 2020. Adult Pulmonary Medicine

Collaborators (6)

Myriam Gharbi

Mark Metersky

Douglas Hornick

Radmila Choate

Daniel Belz

James Blum

Make your next move.